Initial cognitive decline is associated with cortical thinning in early Parkinson disease

Neurology

Volumn 82, Issue 22, 2014, Pages 2017-2025

  Pereira, Joana B ^a   Svenningsson, Per ^b   Weintraub, Daniel ^c   Brønnick, Kolbjørn ^d   Lebedev, Alexander ^e   Westman, Eric ^a   Aarsland, Dag ^a,e  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d Norwegian Center for Movement Disorders Centre for Age Related Medicine   (Norway)

^e STAVANGER UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ATTENTION DISTURBANCE; BRAIN ATROPHY; BRAIN CORTEX ATROPHY; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; DEPTH PERCEPTION; DISEASE MARKER; FEMALE; HUMAN; IMAGE PROCESSING; INFERIOR TEMPORAL CORTEX; MAJOR CLINICAL STUDY; MALE; MANAGER; MEMORY; MILD COGNITIVE IMPAIRMENT; MOTOR DYSFUNCTION; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PRIORITY JOURNAL; SEMANTICS; TASK PERFORMANCE;

AGED; ATROPHY; BIOLOGICAL MARKERS; CEREBRAL CORTEX; FEMALE; GERIATRIC ASSESSMENT; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE;

EID: 84903974354     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000000483     Document Type: Article

References (39)

1. Kehagia AA, Barker RA, Robbins TW. Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's disease. Lancet Neurol 2010;9: 1200-1213.
2. Pagonabarraga J, Kulisevsky J. Cognitive impairment and dementia in Parkinson's disease. Neurobiol Dis 2012;46: 590-596.
3. Williams-Gray CH, Foltynie T, Brayne CE, Robbins TW, Barker RA. Evolution of cognitive dysfunction in an incident Parkinson's disease cohort. Brain 2007;130: 1787-1798.
4. Williams-Gray CH, Evans JR, Goris A, et al. The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort. Brain 2009;132: 2958-2969.
5. Svenningsson P, Westman E, Ballard C, Aarsland D. Cognitive impairment in patients with Parkinson's disease: diagnosis, biomarkers, and treatment. Lancet Neurol 2012;11: 697-707.
6. Bronnick K, Alves G, Aarsland D, Tysnes OB, Larsen JP. Verbal memory in drug-naive, newly diagnosed Parkinson's disease: the retrieval deficit hypothesis revisited. Neuropsychology 2011;25: 114-124.
7. Parkinson Progression Marker Initiative. The Parkinson progression marker initiative (PPMI). Prog Neurobiol 2011;95: 629-635.
8. Simmons A, Westman E, Muehlboeck S, et al. The Add-NeuroMed framework for multi-centre MRI assessment of longitudinal changes in Alzheimer's disease: experience from the first 24 months. Int J Geriatr Psychiatry 2011;26: 75-82.
9. Sheikh JI, Yesavage JA. Geriatric Depression Scale (GDS): recent evidence and development of a shorter version. In: Brink TL, editor. Clinical Gerontology: A Guide to Assessment and Intervention. New York: The Haworth Press; 1986: 165-173.
10. Goetz CG, Fahn S, Martinez-Martin P, et al. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): process, format, and clinimetric testing plan. Mov Disord 2007;22: 41-47.
11. Fahn S, Elton RL; the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Calne D, Goldstein M, editors. Recent Developments in Parkinson's Disease. Florham Park, NJ: Macmillan Health Care Information; 1987: 153-163.
12. Hoehn MH, Yahr MD. Parkinsonism: onset, progression, and mortality. Neurology 1967;17: 427-442.
13. Litvan I, Goldman JG, Troster AI, et al. Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines. Mov Disord 2012;27: 349-356.
14. Dubois B, Burn D, Goetz C, et al. Diagnostic procedures for Parkinson's disease dementia: recommendations from the Movement Disorder Society Task Force. Mov Disord 2007;22: 2314-2324.
15. Aarsland D, Bronnick K, Larsen JP, Tysnes OB, Alves G; Norwegian ParkWest Study Group. Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest Study. Neurology 2009;72: 1121-1126.
16. Aarsland D, Bronnick K, Williams-Gray C, et al. Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis. Neurology 2010;75: 1062-1069.
17. Dale AM, Fischl B, Sereno MI. Cortical surface-based analysis: I: segmentation and surface reconstruction. Neuroimage 1999;9: 179-194.
18. Fischl B, Dale AM. Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc Natl Acad Sci USA 2000;97: 11050-11055.
19. Fischl B, Sereno MI, Dale AM. Cortical surface-based analysis: II: inflation, flattening, and a surface-based coordinate system. Neuroimage 1999;9: 195-207.
20. Fischl B, van der Kouwe A, Destrieux C, et al. Automatically parcellating the human cerebral cortex. Cereb Cortex 2004;14: 11-22.
21. Westman E, Muehlboeck JS, Simmons A. Combining MRI and CSF measures for classification of Alzheimer's disease and prediction of mild cognitive impairment conversion. Neuroimage 2012;62: 229-238.
22. Weintraub D, Doshi J, Koka D, et al. Neurodegeneration across stages of cognitive decline in Parkinson disease. Arch Neurol 2011;68: 1562-1568.
23. Melzer TR, Watts R, MacAskill MR, et al. Grey matter atrophy in cognitively impaired Parkinson's disease. J Neurol Neurosurg Psychiatry 2012;83: 188-194.
24. Compta Y, Parkkinen L, O'Sullivan SS, et al. Lewyand Alzheimer-Type pathologies in Parkinson's disease dementia: which is more important? Brain 2011;134: 1439-1505.
25. Compta Y, Ibarretxe-Bilbao N, Pereira JB, et al. Grey matter volume correlates of cerebrospinal markers of Alzheimer-pathology in Parkinson's disease and related dementia. Parkinsonism Relat Disord 2012;18: 941-947.
26. Compta Y, Pereira JB, Ríos J, et al. Combined dementiarisk biomarkers in Parkinson's disease: a prospective longitudinal study. Parkinsonism Relat Disord 2013;19: 717-724.
27. Duncan GW, Firbank MJ, O'Brien JT, Burn DJ. Magnetic resonance imaging: a biomarker for cognitive impairment in Parkinson's disease? Mov Disord 2013;28: 425-438.
28. Nishio Y, Hirayama K, Takeda A, et al. Corticolimbic gray matter loss in Parkinson's disease without dementia. Eur J Neurol 2010;17: 1090-1097.
29. Lee JE, Park HJ, Song SK, Sohn YH, Lee JD, Lee PH. Neuroanatomic basis of amnestic MCI differs in patients with and without Parkinson disease. Neurology 2010;75: 2009-2016.
30. Song SK, Lee JE, Park HJ, Sohn YH, Lee JD, Lee PH. The pattern of cortical atrophy in patients with Parkinson's disease according to cognitive status. Mov Disord 2011;26: 289-296.
31. Pagonabarraga J, Corcuera-Solano I, Vives-Gilabert Y, et al. Pattern of regional cortical thinning associated with cognitive deterioration in Parkinson's disease. PLoS One 2013;8: e54980.
32. Weintraub D, Dietz N, Duda JE, et al. Alzheimer's disease pattern of brain atrophy predicts cognitive decline in Parkinson's disease. Brain 2012;135: 170-180.
33. Zarei M, Ibarretxe-Bilbao N, Compta Y, et al. Cortical thinning is associated with disease stages and dementia in Parkinson's disease. J Neurol Neurosurg Psychiatry 2013;84: 875-881.
34. Martin A, Chao LL. Semantic memory and the brain: structure and processes. Curr Opin Neurobiol 2001;11: 194-201.
35. Corbetta M, Shulman GL. Control of goal-directed and stimulus driven-Attention in the brain. Nat Rev Neurosci 2002;3: 201-215.
36. Camicioli R, Gee M, Bouchard TP, et al. Voxel-based morphometry reveals extra-nigral atrophy patterns associated with dopamine refractory cognitive and motor impairment in parkinsonism. Parkinsonism Relat Disord 2009;15: 187-195.
37. Pereira JB, Junque C, Marti MJ, Ramirez-Ruiz B, Bargalló N, Tolosa E. Neuroanatomical substrate of visuospatial and visuoperceptual impairment in Parkinson's disease. Mov Disord 2009;24: 1193-1199.
38. Pereira JB, Junque C, Marti MJ, Ramirez-Ruiz B, Bartres-Faz D, Tolosa E. Structural brain correlates of verbal fluency in Parkinson's disease. Neuroreport 2009;20: 741-744.
39. Ibarretxe-Bilbao N, Ramirez-Ruiz B, Junque C, et al. Differential progression of brain atrophy in Parkinson's disease with and without visual hallucinations. J Neurol Neurosurg Psychiatry 2010;81: 650-657.